Palo Alto Investors as of Dec. 31, 2020
Portfolio Holdings for Palo Alto Investors
Palo Alto Investors holds 41 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Staar Surgical Com Par $0.01 (STAA) | 11.8 | $226M | 2.8M | 79.22 | |
| Insmed Com Par $.01 (INSM) | 10.7 | $203M | 6.1M | 33.29 | |
| BioMarin Pharmaceutical (BMRN) | 9.9 | $189M | 2.2M | 87.69 | |
| Amicus Therapeutics (FOLD) | 9.5 | $182M | 7.9M | 23.09 | |
| Abiomed | 9.5 | $181M | 557k | 324.20 | |
| ACADIA Pharmaceuticals (ACAD) | 6.4 | $123M | 2.3M | 53.46 | |
| United Therapeutics Corporation (UTHR) | 6.2 | $119M | 785k | 151.79 | |
| Karyopharm Therapeutics (KPTI) | 4.3 | $82M | 5.3M | 15.48 | |
| Alexion Pharmaceuticals | 4.1 | $79M | 503k | 156.24 | |
| Revance Therapeutics (RVNC) | 4.0 | $76M | 2.7M | 28.34 | |
| Epizyme | 3.8 | $73M | 6.7M | 10.86 | |
| Biogen Idec (BIIB) | 3.0 | $57M | 234k | 244.86 | |
| Vanda Pharmaceuticals (VNDA) | 2.9 | $56M | 4.2M | 13.14 | |
| Sage Therapeutics (SAGE) | 2.7 | $51M | 590k | 86.51 | |
| eHealth (EHTH) | 2.2 | $41M | 587k | 70.61 | |
| Align Technology (ALGN) | 1.9 | $36M | 68k | 534.38 | |
| Clovis Oncology | 1.1 | $22M | 4.5M | 4.80 | |
| Prothena Corp SHS (PRTA) | 1.1 | $20M | 1.7M | 12.01 | |
| Gossamer Bio (GOSS) | 0.9 | $17M | 1.7M | 9.67 | |
| Puma Biotechnology (PBYI) | 0.7 | $14M | 1.4M | 10.26 | |
| Anaptysbio Inc Common (ANAB) | 0.5 | $8.9M | 416k | 21.50 | |
| Dicerna Pharmaceuticals | 0.4 | $7.3M | 332k | 22.03 | |
| Kaleido Biosciences Ord (KLDO) | 0.4 | $7.2M | 786k | 9.10 | |
| Syndax Pharmaceuticals (SNDX) | 0.3 | $5.9M | 264k | 22.24 | |
| Travere Therapeutics (TVTX) | 0.2 | $4.3M | 158k | 27.26 | |
| Zogenix Com New | 0.2 | $4.3M | 215k | 19.99 | |
| Athenex | 0.2 | $3.5M | 318k | 11.06 | |
| Rigel Pharmaceuticals Com New | 0.2 | $3.5M | 998k | 3.50 | |
| Magenta Therapeutics | 0.2 | $3.3M | 427k | 7.84 | |
| Alkermes SHS (ALKS) | 0.2 | $3.0M | 151k | 19.95 | |
| Kezar Life Sciences (KZR) | 0.2 | $2.9M | 548k | 5.22 | |
| Cytokinetics Com New (CYTK) | 0.1 | $2.6M | 124k | 20.78 | |
| Tactile Systems Technology, In (TCMD) | 0.1 | $1.2M | 27k | 44.94 | |
| Aldeyra Therapeutics (ALDX) | 0.1 | $1.1M | 161k | 6.86 | |
| Alimera Sciences Com New | 0.0 | $848k | 201k | 4.22 | |
| Aprea Therapeutics | 0.0 | $634k | 129k | 4.92 | |
| Urogen Pharma (URGN) | 0.0 | $441k | 25k | 18.00 | |
| Marinus Pharmaceuticals | 0.0 | $382k | 31k | 12.19 | |
| Idera Pharmaceuticals Com Par | 0.0 | $283k | 77k | 3.67 | |
| Sunesis Pharmaceuticals Inc Ne | 0.0 | $231k | 116k | 1.99 | |
| Minerva Neurosciences | 0.0 | $85k | 36k | 2.34 |
